GB0220885D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0220885D0
GB0220885D0 GBGB0220885.8A GB0220885A GB0220885D0 GB 0220885 D0 GB0220885 D0 GB 0220885D0 GB 0220885 A GB0220885 A GB 0220885A GB 0220885 D0 GB0220885 D0 GB 0220885D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0220885.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0220885.8A priority Critical patent/GB0220885D0/en
Publication of GB0220885D0 publication Critical patent/GB0220885D0/en
Priority to CA002497182A priority patent/CA2497182A1/en
Priority to EP03750497A priority patent/EP1539186A1/en
Priority to HK06100805.9A priority patent/HK1080734B/xx
Priority to AU2003270154A priority patent/AU2003270154A1/en
Priority to US10/526,282 priority patent/US20060234985A1/en
Priority to JP2004535458A priority patent/JP2006500401A/ja
Priority to CNB038213338A priority patent/CN1327844C/zh
Priority to BR0314081-4A priority patent/BR0314081A/pt
Priority to PCT/EP2003/009972 priority patent/WO2004024165A1/en
Priority to US12/431,347 priority patent/US20090209493A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0220885.8A 2002-09-09 2002-09-09 Organic compounds Ceased GB0220885D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0220885.8A GB0220885D0 (en) 2002-09-09 2002-09-09 Organic compounds
PCT/EP2003/009972 WO2004024165A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
AU2003270154A AU2003270154A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
EP03750497A EP1539186A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
HK06100805.9A HK1080734B (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
CA002497182A CA2497182A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
US10/526,282 US20060234985A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
JP2004535458A JP2006500401A (ja) 2002-09-09 2003-09-08 ビスホスホネートおよびｈｍｇ−ｃｏａレダクターゼインヒビターを含む組合せ治療
CNB038213338A CN1327844C (zh) 2002-09-09 2003-09-08 包含双膦酸类化合物和hmg－coa还原酶抑制剂的组合疗法
BR0314081-4A BR0314081A (pt) 2002-09-09 2003-09-08 Terapia de combinação compreendendo um bisfosfonato e um inibidor de hmg-coa redutase
US12/431,347 US20090209493A1 (en) 2002-09-09 2009-04-28 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0220885.8A GB0220885D0 (en) 2002-09-09 2002-09-09 Organic compounds

Publications (1)

Publication Number Publication Date
GB0220885D0 true GB0220885D0 (en) 2002-10-16

Family

ID=9943733

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0220885.8A Ceased GB0220885D0 (en) 2002-09-09 2002-09-09 Organic compounds

Country Status (9)

Country Link
US (2) US20060234985A1 (enExample)
EP (1) EP1539186A1 (enExample)
JP (1) JP2006500401A (enExample)
CN (1) CN1327844C (enExample)
AU (1) AU2003270154A1 (enExample)
BR (1) BR0314081A (enExample)
CA (1) CA2497182A1 (enExample)
GB (1) GB0220885D0 (enExample)
WO (1) WO2004024165A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327742D0 (en) * 2003-11-28 2003-12-31 Isis Innovation Novel uses of known drugs
US8012949B2 (en) 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
US7358361B2 (en) 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US7687482B2 (en) 2006-03-17 2010-03-30 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
FR2903312B1 (fr) 2006-07-05 2008-09-26 Univ Aix Marseille Ii Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament
BRPI0821962A2 (pt) * 2008-01-03 2019-05-07 Univ De La Mediterrannee Aix Marseille Ii composições e métodos usados durante um tratamento anti-hiv
ES2339524B1 (es) * 2008-08-28 2011-03-22 Proyecto De Biomedicina Cima, S.L. Nuevo biomarcador como diana terapeutica en cancer de pulmon.
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
KR101813728B1 (ko) 2009-07-31 2017-12-29 그뤼넨탈 게엠베하 결정화 방법 및 생체이용률
EP2533764A4 (en) * 2010-02-08 2016-08-31 Univ Nebraska BIOMINERAL AND METAL BINDING LIPOSOME, THEIR SYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
WO2012071517A2 (en) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Novel crystalline forms
WO2012170417A2 (en) 2011-06-06 2012-12-13 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080779A (en) * 1996-12-13 2000-06-27 Osteoscreen, Inc. Compositions and methods for stimulating bone growth
US20010025028A1 (en) * 1998-03-13 2001-09-27 Merck & Co., Inc. Methods of inhibiting bone resorption
JP2002506030A (ja) * 1998-03-13 2002-02-26 メルク エンド カムパニー インコーポレーテッド 骨再吸収の阻害方法
YU68900A (sh) * 1998-05-12 2002-12-10 Warner-Lambert Company Kombinacije inhibitora protein farnesiltransferaze i hmg coa reduktaze i njihova upotreba u tretmanu raka
US20020028826A1 (en) * 2000-06-15 2002-03-07 Robl Jeffrey A. HMG-CoA reductase inhibitors and method
US6620821B2 (en) * 2000-06-15 2003-09-16 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
AU2002213050A1 (en) * 2000-10-06 2002-04-15 F. Timothy Guilford A combination and method of treatment of cancer utilizing a cox-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (hmg-coa) reductase inhibitor

Also Published As

Publication number Publication date
US20060234985A1 (en) 2006-10-19
HK1080734A1 (en) 2006-05-04
AU2003270154A1 (en) 2004-04-30
CN1327844C (zh) 2007-07-25
CN1681515A (zh) 2005-10-12
EP1539186A1 (en) 2005-06-15
BR0314081A (pt) 2005-07-05
WO2004024165A1 (en) 2004-03-25
US20090209493A1 (en) 2009-08-20
JP2006500401A (ja) 2006-01-05
CA2497182A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
GB0203276D0 (en) Organic compounds
GB0202873D0 (en) Organic compounds
GB0209265D0 (en) Organic compounds
GB0220885D0 (en) Organic compounds
GB0200429D0 (en) Organic compounds
EG23462A (en) Organic compounds
GB0209481D0 (en) Organic compounds
GB0203061D0 (en) Organic compounds
GB0202874D0 (en) Organic compounds
GB0204756D0 (en) Organic compounds
GB0209257D0 (en) Organic compounds
GB0210257D0 (en) Organic compounds
GB0209886D0 (en) Organic compounds
GB0201913D0 (en) Organic compounds
GB0201881D0 (en) Organic compounds
GB0201610D0 (en) Organic compounds
GB0201609D0 (en) Organic compounds
GB0201181D0 (en) Organic compounds
GB0200940D0 (en) Organic compounds
GB0200587D0 (en) Organic compounds
GB0202755D0 (en) Organic compounds
GB0202875D0 (en) Organic compounds
GB0204763D0 (en) Organic compounds
GB0210371D0 (en) Organic compounds
GB0203189D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)